Precision Medical Sciences

Wiley

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Precision Medical Sciences is an open-access journal published by Wiley in Australia, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,200 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
2642-2514
Country
Australia
Languages
english
Access
Open access
Declared publication charge
2,200 USD
Articles in DOAJ
137
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2020-10-06
Indexing
DOAJ
APC
2,200 USD
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

137

Most recent article

4 months ago

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

210

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

8

i10-index

8

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-17
Added to DOAJ
2020-10-06
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
77%
ORCID iDs in current deposits
68%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Continues
2227-6394
Source type
journal
Society affiliations
Jiangsu Cancer Hospital
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer survivorship and care
  • Cancer survivorship and care
  • Ferroptosis and cancer prognosis
  • Human auditory perception and evaluation
  • Ferroptosis and cancer prognosis
  • Educational Robotics and Engineering
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
Show all subjects (50)
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Cancer Genomics and Diagnostics
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Cancer Genomics and Diagnostics
  • MicroRNA in disease regulation
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation
  • Cancer Immunotherapy and Biomarkers
  • Healthcare Systems and Public Health
  • Cancer Immunotherapy and Biomarkers
  • Healthcare Systems and Public Health
  • Cancer-related cognitive impairment studies
  • Esophageal Cancer Research and Treatment
  • Circular RNAs in diseases
  • Esophageal Cancer Research and Treatment
  • Cancer-related cognitive impairment studies
  • Circular RNAs in diseases
  • Advanced Breast Cancer Therapies
  • Lung Cancer Research Studies
  • Palliative Care and End-of-Life Issues
  • Palliative Care and End-of-Life Issues
  • Lung Cancer Research Studies
  • Lung Cancer Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Advanced Breast Cancer Therapies
  • Lung Cancer Diagnosis and Treatment
  • Gastric Cancer Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Head and Neck Cancer Studies
  • Breast Cancer Treatment Studies
  • BRCA gene mutations in cancer
  • Bladder and Urothelial Cancer Treatments
  • BRCA gene mutations in cancer
  • Prostate Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Lung Cancer Treatments and Mutations
  • Bladder and Urothelial Cancer Treatments
  • Breast Cancer Treatment Studies
  • Prostate Cancer Diagnosis and Treatment

Keywords (DOAJ)

  • precision medicine
  • oncology
  • clinical medicine
  • personalised medicine
  • individualised therapy

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: